ASCO-SITC Clinical Immuno-Oncology Symposium

Starts:  Feb 6, 2020 12:00 AM (ET)
Ends:  Feb 8, 2020 12:00 AM (ET)
The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care.​ This meeting addresses the high-level of need for clinical education in a field where all aspects of care are fundamentally different from traditional therapies.

Why Should you Attend this Meeting?

  • CONNECT: Meet faculty members and fellow attendees from around the world in both formal and informal networking events.

  • DISCOVER: Attend education and science sessions that explore pioneering clinical and translational research and breakthroughs in immuno-oncology and its implications for patient care.

  • ENGAGE: Ask expert faculty your most pressing questions in extended Question and Answer panels. Visit the exhibits to expand your understanding of the most advanced therapies, products, and upcoming research.

  • GET CREDIT: Earn CME credit and MOC points from ABIM and ABAI for attending the Symposium.


SITC Organizers
Mario Sznol, MD* – Yale Cancer Center (SITC President)
Lawrence Fong, MD* – University of California San Francisco
Hussein Tawbi, MD, PhD* – MD Anderson Cancer Center
Michael Sadelain, MD, PhD – Memorial Sloan Kettering Cancer Center
Madhav V. Dhodapkar, MBBS* – Emory University
Jennifer A. Wargo, MD, MMSc* – MD Anderson Cancer Center

ASCO Organizers
Stephen Gottschalk, MD* – St. Jude Children's Research Hospital
Kunle Odunsi, MD, PhD* – Roswell Park Comprehensive Cancer Center
Robert Dreicer, MD, MS, MACP, FASCO – University of Virginia Cancer Center
Dung T. Le, MD – Johns Hopkins Univeristy
Allison Betof-Warner, MD, PhD – Memorial Sloan Kettering Cancer Center
Edward B. Garon, MD, MS* – University of California Los Angeles

*Denotes SITC Member

To find out more information, please click here